Corporate DisclosureBXPHARMA
BXPHARMA Corporate Disclosure — 6 November 2023
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 6 November 2023. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Continuation news of BXPHARMA): Reasons for deviation in NOCFPS: In the first quarter of comparable prior year, cash out flows for inventories were notably higher because of strategic buildup of inventories to protect against any supply chain disruption. This, together with improved working capital and revenue growth, resulted in a positive deviation in current period's Operating Cash Flows per share. (end)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 65485e6c9b63f842125a1fd0
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.